Zhejiang Runyang New Material Technology Co., Ltd.

SZSE:300920 Stock Report

Market Cap: CN¥1.7b

Zhejiang Runyang New Material Technology Balance Sheet Health

Financial Health criteria checks 4/6

Zhejiang Runyang New Material Technology has a total shareholder equity of CN¥1.2B and total debt of CN¥83.0M, which brings its debt-to-equity ratio to 7.1%. Its total assets and total liabilities are CN¥1.4B and CN¥187.8M respectively. Zhejiang Runyang New Material Technology's EBIT is CN¥37.0M making its interest coverage ratio -2.4. It has cash and short-term investments of CN¥496.8M.

Key information

7.1%

Debt to equity ratio

CN¥83.00m

Debt

Interest coverage ratio-2.4x
CashCN¥496.85m
EquityCN¥1.18b
Total liabilitiesCN¥187.79m
Total assetsCN¥1.36b

Recent financial health updates

No updates

Recent updates

There's Reason For Concern Over Zhejiang Runyang New Material Technology Co., Ltd.'s (SZSE:300920) Price

Sep 27
There's Reason For Concern Over Zhejiang Runyang New Material Technology Co., Ltd.'s (SZSE:300920) Price

Zhejiang Runyang New Material Technology Co., Ltd. (SZSE:300920) Surges 29% Yet Its Low P/E Is No Reason For Excitement

May 21
Zhejiang Runyang New Material Technology Co., Ltd. (SZSE:300920) Surges 29% Yet Its Low P/E Is No Reason For Excitement

Be Wary Of Zhejiang Runyang New Material Technology (SZSE:300920) And Its Returns On Capital

Apr 23
Be Wary Of Zhejiang Runyang New Material Technology (SZSE:300920) And Its Returns On Capital

Zhejiang Runyang New Material Technology Co., Ltd. (SZSE:300920) Investors Are Less Pessimistic Than Expected

Mar 06
Zhejiang Runyang New Material Technology Co., Ltd. (SZSE:300920) Investors Are Less Pessimistic Than Expected

Financial Position Analysis

Short Term Liabilities: 300920's short term assets (CN¥748.2M) exceed its short term liabilities (CN¥161.2M).

Long Term Liabilities: 300920's short term assets (CN¥748.2M) exceed its long term liabilities (CN¥26.6M).


Debt to Equity History and Analysis

Debt Level: 300920 has more cash than its total debt.

Reducing Debt: 300920's debt to equity ratio has increased from 3.2% to 7.1% over the past 5 years.

Debt Coverage: 300920's debt is not well covered by operating cash flow (11.1%).

Interest Coverage: 300920 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies